CIK 0001401040 · Non-accelerated filer<br>Smaller reporting company
DiaMedica Therapeutics Inc.
Sign in to watch- Ticker
- DMAC
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Canada (Federal Level)
- Entity type
- operating
- Phone
- (763) 496-5454
- Business address
- 301 CARLSON PARKWAY, SUITE 210, MINNEAPOLIS, MN, 55305
- Former names
- DiaMedica Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-11-18 | STAHLBERG JAN 10% owner | Purchase | +182,882 | $6.75 | $1.2M | 8,134,740 |
| 2025-11-17 | STAHLBERG JAN 10% owner | Purchase | +187,393 | $6.52 | $1.2M | 7,951,858 |
| 2025-08-27 | STAHLBERG JAN 10% owner | Purchase | +50,772 | $6.00 | $305K | 7,764,465 |
| 2025-08-26 | STAHLBERG JAN 10% owner | Purchase | +59,648 | $6.00 | $358K | 7,713,693 |
| 2025-08-25 | STAHLBERG JAN 10% owner | Purchase | +338,265 | $6.00 | $2.0M | 7,654,045 |
| 2025-08-22 | STAHLBERG JAN 10% owner | Purchase | +59,788 | $5.96 | $357K | 7,315,780 |
| 2025-08-21 | STAHLBERG JAN 10% owner | Purchase | +48,172 | $5.96 | $287K | 7,255,992 |
| 2025-08-20 | STAHLBERG JAN 10% owner | Purchase | +71,107 | $5.86 | $416K | 7,207,820 |
| 2025-08-15 | STAHLBERG JAN 10% owner | Purchase | +8,233 | $6.00 | $49K | 7,136,713 |
| 2025-08-14 | STAHLBERG JAN 10% owner | Purchase | +70,414 | $5.99 | $422K | 7,128,480 |
| 2025-08-13 | STAHLBERG JAN 10% owner | Purchase | +293,601 | $5.91 | $1.7M | 7,058,066 |
| 2025-08-11 | Krop Julie Chief Marketing Officer | Grant or award · Stock Option (right to buy) | +450,000 | 450,000 | ||
| 2025-07-23 | JACINTO RICHARD II 10% owner | Purchase | +400,000 | $3.50 | $1.4M | 4,958,823 |
| 2025-07-23 | STAHLBERG JAN 10% owner | Purchase | +1,542,857 | $3.50 | $5.4M | 6,764,465 |
| 2025-07-23 | Von Koch Thomas 10% owner | Purchase | +2,857,142 | $3.50 | $10.0M | 8,383,577 |
| 2025-06-01 | Wambeke David J. Chief Business Officer | Grant or award · Stock Option (right to buy) | +250,000 | 250,000 | ||
| 2025-06-01 | Semba Charles Pauling Director | Grant or award · Stock Option (right to buy) | +32,162 | 32,162 | ||
| 2025-06-01 | Pauls Dietrich John President & CEO | Grant or award · Stock Option (right to buy) | +600,000 | 600,000 | ||
| 2025-06-01 | Parsons James T. Director | Grant or award · Stock Option (right to buy) | +40,739 | 40,739 | ||
| 2025-06-01 | Lewis Tanya Director | Grant or award · Stock Option (right to buy) | +32,162 | 32,162 |
Page 2 of 10 · 189 trades